Kaaya BD - Search Results

1

Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand.

ACTwatch Group; Phok S, Phanalasy S, Thein ST, Likhitsup A. ACTwatch Group, et al. Malar J. 2017 May 2;16(1):180. doi: 10.1186/s12936-017-1800-5. Malar J. 2017. PMID: 28464945 Free PMC article. Review.

2

The malaria testing and treatment landscape in Benin.

ACTwatch Group; Zinsou C, Cherifath AB. ACTwatch Group, et al. Malar J. 2017 Apr 26;16(1):174. doi: 10.1186/s12936-017-1808-x. Malar J. 2017. PMID: 28446236 Free PMC article.

3

The malaria testing and treatment landscape in mainland Tanzania, 2016.

ACTwatch Group; Michael D, Mkunde SP. ACTwatch Group, et al. Malar J. 2017 Apr 24;16(1):202. doi: 10.1186/s12936-017-1819-7. Malar J. 2017. PMID: 28521811 Free PMC article.

4

Private sector role, readiness and performance for malaria case management in Uganda, 2015.

ACTwatch Group; Kaula H, Buyungo P, Opigo J. ACTwatch Group, et al. Malar J. 2017 May 25;16(1):219. doi: 10.1186/s12936-017-1824-x. Malar J. 2017. PMID: 28545583 Free PMC article.

5

When it just won't go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress.

ACTwatch Group; Ujuju C, Anyanti J, Newton PN, Ntadom G. ACTwatch Group, et al. Malar J. 2017 Dec 15;16(1):489. doi: 10.1186/s12936-017-2102-7. Malar J. 2017. PMID: 29246208 Free PMC article.

6

The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016.

ACTwatch Group; Musuva A, Ejersa W, Kiptui R, Memusi D, Abwao E. ACTwatch Group, et al. Malar J. 2017 Dec 21;16(1):494. doi: 10.1186/s12936-017-2089-0. Malar J. 2017. PMID: 29268789 Free PMC article.

7

Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries.

ACTwatch Group; Newton PN, Hanson K, Goodman C. ACTwatch Group, et al. Malar J. 2017 May 25;16(1):204. doi: 10.1186/s12936-017-1818-8. Malar J. 2017. PMID: 28539125 Free PMC article.

8

Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey.

ACTwatch Group; Thein ST, Khin HSS, Thi A. ACTwatch Group, et al. Malar J. 2017 Apr 25;16(1):170. doi: 10.1186/s12936-017-1793-0. Malar J. 2017. PMID: 28438145 Free PMC article.

9

What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.

ACTwatch Group; Tougher S, Hanson K, Goodman C. ACTwatch Group, et al. Malar J. 2017 Apr 25;16(1):173. doi: 10.1186/s12936-017-1814-z. Malar J. 2017. PMID: 28441956 Free PMC article.

10

Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies.

ACTwatch Group; Phok S, Lek D. ACTwatch Group, et al. Malar J. 2017 Apr 25;16(1):171. doi: 10.1186/s12936-017-1807-y. Malar J. 2017. PMID: 28438204 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters